Elgan Pharma

ELGAN Pharma is a biotechnology company focused on neonatology, dedicated to developing safe, customized therapies to address common medical issues and developmental challenges in premature infants. The company’s two leading projects are ELGN-GI for treating intestinal malabsorption in preterm infants and ELGN-EYE for treating retinopathy of prematurity, the leading cause of childhood blindness worldwide.